MedTrace Logo

Omnaris Versus Levocetirizine Phase 4 Study

NCT01430260 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 349

Last updated 2012-09-06

No results posted yet for this study

Summary

This i a comparison of the efficacy ciclesonide nasal spray and levocetirizine, alone and in combination.

Conditions

  • Allergic Rhinitis

Interventions

DRUG

Ciclesonide

200 ㎍ once daily

DRUG

Levocetirizine

5mg once daily

DRUG

Ciclesonide & Levocetirizine

* Omnaris (ciclesonide) 200 ㎍ once daily * Levocetirizine 5mg once daily

Sponsors & Collaborators

  • Takeda

    collaborator INDUSTRY

  • Handok Inc.

    lead INDUSTRY

Principal Investigators

  • Moonhwa Park, Doctor · Handok Inc.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2012-07-31
Completion
2012-07-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01430260 on ClinicalTrials.gov